Preserflo MicroShunt in refractory glaucoma: multicentre european results with up to three years of follow-up.
Fang Clarissa Ern Hui, Fea Antonio Maria, Economou Mario A, Fenerty Cecilia, Yau Kenneth, Yu Jonathan et al.
The Preserflo MicroShunt effectively lowered IOP and reduced glaucoma medications over three years in refractory patients, demonstrating sustained efficacy and safety for long-term management.